Regeneron Pharmaceuticals
REGN
#232
Rank
โ‚ฌ87.15 B
Marketcap
842,50ย โ‚ฌ
Share price
0.22%
Change (1 day)
38.36%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚ฌ4.96 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ16.89 Billion. In 2025 the company made an earning of โ‚ฌ4.76 Billion, an increase over its 2024 earnings that were of โ‚ฌ4.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ4.96 B4.08%
2025 โ‚ฌ4.76 B9.43%
2024 โ‚ฌ4.35 B13.83%
2023 โ‚ฌ3.82 B-13.57%
2022 โ‚ฌ4.42 B-47.9%
2021 โ‚ฌ8.49 B144.75%
2020 โ‚ฌ3.47 B56.86%
2019 โ‚ฌ2.21 B-4.87%
2018 โ‚ฌ2.32 B22.86%
2017 โ‚ฌ1.89 B56.3%
2016 โ‚ฌ1.21 B8.55%
2015 โ‚ฌ1.11 B54.53%
2014 โ‚ฌ0.72 B11.14%
2013 โ‚ฌ0.65 B72.13%
2012 โ‚ฌ0.37 B-285.93%
2011 -โ‚ฌ0.21 Billion121.73%
2010 -โ‚ฌ91.62 Million37.18%
2009 -โ‚ฌ66.79 Million-14.6%
2008 -โ‚ฌ78.21 Million-25.02%
2007 -โ‚ฌ0.11 Billion6.32%
2006 -โ‚ฌ98.12 Million-186.52%
2005 โ‚ฌ0.11 B2103.7%
2004 โ‚ฌ5.14 M-105.66%
2003 -โ‚ฌ90.94 Million-18.18%
2002 -โ‚ฌ0.12 Billion42.33%
2001 -โ‚ฌ78.1 Million129.35%
2000 -โ‚ฌ34.05 Million51.87%
1999 -โ‚ฌ22.43 Million92.19%
1998 -โ‚ฌ11.67 Million66.23%
1997 -โ‚ฌ7.02 Million-55.49%
1996 -โ‚ฌ15.77 Million103.53%
1995 -โ‚ฌ7.75 Million-70.89%
1994 -โ‚ฌ26.62 Million-26.08%
1993 -โ‚ฌ36.01 Million114.67%
1992 -โ‚ฌ16.77 Million196.77%
1991 -โ‚ฌ5.66 Million87.88%
1990 -โ‚ฌ3.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B 229.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ11.52 B 122.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚ฌ10.07 B 94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.09 B 36.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ0.40 B-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ1.11 B-78.52%๐Ÿ‡บ๐Ÿ‡ธ USA